Background COVID-19 related in-hospital venous thromboembolism (VTE) incidence is high
but data reported vary significantly. Some studies show that up to half of the events are …

Background The aim of this study was to detail the incidence of venous thromboembolism
(VTE) in patients hospitalised with COVID-19 in England. Methods This was an exploratory …

Background Patients with COVID-19 infection are commonly reported to have an increased
risk of venous thrombosis. The choice of anti-thrombotic agents and doses are currently …

Introduction COVID‐19 predisposes patients to a higher risk of venous thromboembolism
(VTE), although the extent of these implications is unclear and the risk of bleeding has been …

Thank you for a very interesting study by Sjöland et al.[1]. This study is a population-based
register cohort study from Sweden investigating the long-term risk of venous …

Background There are few data on the incidence of thrombosis among COVID-19 cases,
with most research concentrated on hospitalised patients. We aimed to estimate the …

Abstract Coronavirus disease (COVID-19) is caused by the novel severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and is responsible for the ongoing 2019–2020 …

Background: Coagulation disorders are frequently encountered among patients infected
with coronavirus disease 2019 (COVID-19), especially among admitted patients with more …

To establish the impact of COVID-19 on the pre-test probability for VTE in patients with
suspected VTE. This was a retrospective, observational, cross-sectional study of patients 18 …

Emerging evidence shows that the recent pandemic of coronavirus disease 19 (COVID-19)
is characterized by coagulation activation and endothelial dysfunction. This increases the …